clinical Response of Joint Infiltration in Hip Osteoarthritis with Orthobiologics

Phase 1

• Conditions: Osteoarthritis, hip; A02.835.583

• Registration Number: RBR-8zwgpyg
• Lead Sponsor: Fundação Universidade Federal de Sergipe

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2024-03-21
• Last Update Posted: 2 April 2024
• Study Completion: 2025-08-10

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Individuals who have had pain or swelling in the hip (symptoms relevant to hip joint pain) for at least 4 months; Kellgren-Lawrence grade between 1 and 3 on radiographic evaluation; over 18 years old; both genders

Exclusion Criteria

Patients who have undergone a corticosteroid hip joint infiltration within 3 months; or a Hialuronic Acid -HA joint infiltration within 6 months or history of any of the following medical conditions:diabetes, autoimmune disorders, disorders that require immunosuppression, rheumatoid arthritis, infectious arthritis, history of cancer, neurological condition that compromises gait or any other that compromises the level of consciousness, ongoing infectious diseases, kidney and liver diseases and osteonecrosis of the femoral head with collapse secondary to sickle cell anemia

Study & Design

• Study Type: Intervention
• Study Design: Not specified